NHMRC Ideas Grant success for Dr Adi Idris

Dr Adi Idris, from the QUT School of Biomedical Sciences, will lead a $1,550,922 project titled, Developing a universal direct acting antiviral nasal spray against multiple respiratory viruses.

The project aims to develop a self-administered, universal, antiviral nasal spray that treats the most common respiratory viruses, including COVID 19, human metapneumovirus, influenza A and respiratory syncytial virus at the point of entry to the body.

“We propose a novel molecular therapy targeted at inhibiting the replication of multiple viruses using gene-silencing technology in a single nasal spray formulation,” Dr Idris said.

Read full story